Observational studyInternational journal of hematology2024

Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan.

Akira Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.